Lipid Nanocarrier-Based Mrna Therapy: Challenges and Promise for Clinical Transformation

Wenchao Li,Chen Wang,Yifei Zhang,Yuan Lu
DOI: https://doi.org/10.1002/smll.202310531
IF: 13.3
2024-01-01
Small
Abstract:Due to the outbreak of novel coronavirus pneumonia, messenger RNA (mRNA) technology has attracted heated attention. A specific, safe, and efficient mRNA delivery system is needed. Lipid nanocarriers have become attractive carriers for mRNA delivery due to their high delivery efficiency, few side effects, and easy modification to change their structures and functions. To achieve the desired biological effect, lipid nanocarriers must reach the designated location for effective drug delivery. Therefore, the effects of the composition of lipid nanocarriers on their key properties are briefly reviewed. In addition, the progress of smart drug delivery by changing the composition of lipid nanocarriers is summarized, and the importance of component design and structure is emphasized. Subsequently, this review summarizes the latest progress in lipid nanocarrier-based mRNA technology and provides corresponding strategies for its current challenges, putting forward valuable information for the future design of lipid nanocarriers and mRNA. Benefiting from the development of lipid nanocarriers and mRNA technologies, lipid nanocarrier-based mRNA therapies are being developed for use in infectious disease vaccines, cancer immunotherapy, gene editing, and protein replacement therapy. Various methods for optimizing lipid nanocarriers are developed to overcome the targeting, stability, safety, and repeatability of delivery systems. image
What problem does this paper attempt to address?